InvestorsHub Logo

boston745

12/03/18 7:15 PM

#21057 RE: SmokerX #21056

Trying to process this. So K2M and Spinal kinetics left them hanging?



Quite the opposite, they terminated or allowed the deals to expire as the deals seemed to have terminated after the R&D agreement.

My faith is in the published science which continues to pile up. Not sure how you can be pessimistic knowing the R&D agreement is still very much in place? R&D agreement trumps CTL deal any day as the development agreement is developing multiple products. Dont forget this agreement was buried at the bottom of their 10K over 2 years after it was signed.

CTL deal aligns with the quote from 2011. Besides its now apparent the goal of Valeo was simply to keep the company going until they could move forward with Hip & knee and to provide a vehicle for accumulation of clinical data. Valeo was a means to an end.